CN Patent
CN101926097B — 采用通信信道的穿体通信系统
Assigned to Otsuka Pharmaceutical Co Ltd · Expires 2016-10-05 · 10y expired
What this patent protects
提供了采用通信信道的穿体通信系统。各个方面包括例如:体内发射器,用以传送编码信号;穿体功能模块,用以促进编码信号的通信;以及接收器,用以接收编码信号。也提供了方法和设备。
USPTO Abstract
提供了采用通信信道的穿体通信系统。各个方面包括例如:体内发射器,用以传送编码信号;穿体功能模块,用以促进编码信号的通信;以及接收器,用以接收编码信号。也提供了方法和设备。
Drugs covered by this patent
- Abilify (aripiprazole) · Generic (originally Otsuka/BMS)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.